… Our results indicate a low thromboembolic risk after successful AF ablation. Previous
history of IS/TIA/SE and diabetes mellitus were independently associated with an increased …

… less effective for preventing VTE in … thromboembolic events in AF, some studies have
suggested poorer performance of rivaroxaban (vs dabigatran)Citation 45 , while other studies have …

… continuing oral anticoagulation (OAC) after catheter ablation (CA) for atrial fibrillation (AF) is
… There was no benefit of continuation of OAC after successful CA of AF if CHA 2 DS 2 VASc …

… Since 2009, four direct oral anticoagulants (DOACs) have been compared with VKA therapy
… Following ablation, regardless of the success of the procedure, there is consensus among …

… In summary, DOACs have been found to be safer and more effective than warfarin for the …
on VTE treatment have shown that, for both young and elderly patients, DOACs have similar …

… the efficacy and safety of direct oral anticoagulants (DOACs) in a subgroup of patients with
… Atrial fibrillation (AF) is associated with high risk for stroke and systemic embolism. The …

… oral anticoagulants are underused and often underdosed in the prevention of stroke in older
patients with atrial fibrillation because of concerns about the risk … institute safe and effective …

… Atrial fibrillation (AF) is a major risk factor for disabling stroke. Oral anticoagulation reduces
the risk of … Successful treatment of chronic kidney or liver disease may contribute to improve …

… OAC therapy after CA according to the thromboembolic risk. … of continuing OACs after CA
and the occurrence of thromboembolic and … continuing OACs according to thromboembolic risk. …

… An effective and safe oral anticoagulation (OAC) strategy for patients with new postoperative
AF (POAF) after … and 1) thromboembolic events and 2) major bleeding in patients with POAF …